GenScript Peptides: difference between revisions
Diff·revision 10 → 11·23:08, 22 Oct 2025
Difference between revision 10 and revision 11 of GenScript Peptides. 4 lines changed; the page grew by 728 bytes.
| Revision 10 — 16:12, 15 Oct 2025 StubSorterBot (talk) bot: mark outbound storefront link nofollow 7,275 bytes ±0 | Revision 11 — 23:08, 22 Oct 2025 DrTitration (talk) state which lines are held in regional stock 8,003 bytes +728 | ||
|---|---|---|---|
| 12 | | Official site = [https://genscriptpeptides.com/ Visit GSP at genscriptpeptides.com] | 12 | | Official site = [https://genscriptpeptides.com/ Visit GSP at genscriptpeptides.com] |
| 13 | }} | 13 | }} |
| + | 14 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | |
| 14 | 15 | ||
| 15 | '''GenScript Biotech Corporation''' (trading as '''GSP'''; genscriptpeptides.com) is a peptide synthesis organisation trading as GenScript Peptides from Nanjing, Jiangsu, China, incorporated in 2002 and supplying research peptides, custom sequences and raw materials with batch documentation.{{r|registry,selfpub}} | 16 | '''GenScript Biotech Corporation''' (trading as '''GSP'''; genscriptpeptides.com) is a peptide synthesis organisation trading as GenScript Peptides from Nanjing, Jiangsu, China, incorporated in 2002 and supplying research peptides, custom sequences and raw materials with batch documentation.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 36 | One operational observation recurs often enough in the submitted set to belong in the article, and it is not about material. Purchasers describe a delay of four to five working days in obtaining a written quotation for a custom sequence, against same-day acknowledgement on catalogue enquiries; work performed against an accepted quotation is described as meeting its stated date.{{r|reports}} The distinction matters to a reader planning a schedule and is recorded for that reason rather than as a criticism of the material. | 37 | One operational observation recurs often enough in the submitted set to belong in the article, and it is not about material. Purchasers describe a delay of four to five working days in obtaining a written quotation for a custom sequence, against same-day acknowledgement on catalogue enquiries; work performed against an accepted quotation is described as meeting its stated date.{{r|reports}} The distinction matters to a reader planning a schedule and is recorded for that reason rather than as a criticism of the material. |
| 37 | 38 | ||
| + | 39 | What the record does not establish is the physical arrangement of manufacture, whether any given line is synthesised in-house or contracted out, or what quality system governs it. Statements to that effect in the organisation's own material are self-published and are not corroborated here.{{r|selfpub,gmp}} | |
| + | 40 | ||
| 38 | == References == | 41 | == References == |
| 39 | {{reflist}} | 42 | {{reflist}} |
| ⋮ | ⋮ | ||
| 44 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | 47 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> |
| 45 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 48 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| + | 49 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | |
| 46 | 50 | ||
| 47 | {{DEFAULTSORT:GenScript Peptides}} | 51 | {{DEFAULTSORT:GenScript Peptides}} |